Pharmaceuticals, Biotechnology and Life Sciences
SAN FRANCISCO, Oct. 20, 2021 (GLOBE NEWSWIRE) — Neurona Therapeutics, a biotherapeutics company advancing restorative neural cell therapies for the…
SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the…
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 20, 2021 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the…
BOSTON, Oct. 20, 2021 (GLOBE NEWSWIRE) — Radius Health, Inc. (NASDAQ: RDUS) announced today that it will release its third…
ImCheck Publishes Comprehensive Overview of the DevelopmentResults of Its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Vγ9Vδ2 T Cellsin Science…
COVISTIX has received CE mark and marketing authorization from FAMHP (Federal Agency for Medicines and Health Products) that enables Sorrento…
Company announcement no. 11/2021 Please see attachment. For further information please contact: Anders Mohr Christensen, Vice President Group Strategy & Investor…
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK…
Studies to use genome wide functional genetic techniques to identify effective drug combinations and new drug targets for its lead…
BUFFALO, N.Y., Oct. 20, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on…